ID

34576

Description

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01925755

Lien

https://clinicaltrials.gov/show/NCT01925755

Mots-clés

  1. 19/01/2019 19/01/2019 -
  2. 28/09/2020 28/09/2020 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

19 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Stroke, NCT01925755

Eligibility Stroke, NCT01925755

  1. StudyEvent: Eligibility
    1. Eligibility Stroke, NCT01925755
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female patients ≥ 18 years old who start treatment with rivaroxaban
Description

ID.1

Type de données

boolean

non-valvular atrial fibrillation is documented in patients' file
Description

ID.2

Type de données

boolean

prior tia/stroke history
Description

ID.3

Type de données

boolean

tia - more than 72 hours after documented tia
Description

ID.4

Type de données

boolean

more than 2 weeks after non-hemorrhagic stroke
Description

ID.5

Type de données

boolean

written informed consent
Description

ID.6

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications for use of xarelto® in accordance with approved product label
Description

ID.7

Type de données

boolean

previous thromboprophylaxis treatment with anticoagulants prior toby reason of stroke
Description

ID.8

Type de données

boolean

/ tia prevention
Description

ID.9

Type de données

boolean

any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
Description

ID.10

Type de données

boolean

Similar models

Eligibility Stroke, NCT01925755

  1. StudyEvent: Eligibility
    1. Eligibility Stroke, NCT01925755
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male and female patients ≥ 18 years old who start treatment with rivaroxaban
boolean
ID.2
Item
non-valvular atrial fibrillation is documented in patients' file
boolean
ID.3
Item
prior tia/stroke history
boolean
ID.4
Item
tia - more than 72 hours after documented tia
boolean
ID.5
Item
more than 2 weeks after non-hemorrhagic stroke
boolean
ID.6
Item
written informed consent
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
contraindications for use of xarelto® in accordance with approved product label
boolean
ID.8
Item
previous thromboprophylaxis treatment with anticoagulants prior toby reason of stroke
boolean
ID.9
Item
/ tia prevention
boolean
ID.10
Item
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial